Search

Author/Creator Lin, Alyse

1. Extension of the Alternative Intravenous Dosing Regimens of Atezolizumab into Combination Settings through Modeling and Simulation. (11th June 2022)

Authors:
Liu, Stephanie N.; Marchand, Mathilde; Liu, Xiaoyan; Ingle, Gladys; Maiya, Vidya; Graupner, Vilma; Elze, Markus C.; Chan, Phyllis; Hsu, Joy C.; Lin, Alyse; Vadhavkar, Shweta; Wu, Benjamin; Bruno, Rene
Journal:
Journal of clinical pharmacology
Issue:
Volume 62:Number 11(2022)
Page Start:
1393
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Prediction of overall survival in patients across solid tumors following atezolizumab treatments: A tumor growth inhibition–overall survival modeling framework. (4th August 2021)

Authors:
Chan, Phyllis; Marchand, Mathilde; Yoshida, Kenta; Vadhavkar, Shweta; Wang, Nina; Lin, Alyse; Wu, Benjamin; Ballinger, Marcus; Sternheim, Nitzan; Jin, Jin Y.; Bruno, René
Journal:
CPT: pharmacometrics & systems pharmacology
Issue:
Volume 10:Number 10(2021)
Page Start:
1171
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Volunteers Treated With GDC‐0853, a Selective Reversible Bruton's Tyrosine Kinase Inhibitor. Issue 6 (23rd March 2018)

Authors:
Herman, Ann E.; Chinn, Leslie W.; Kotwal, Shweta G.; Murray, Elaine R.; Zhao, Rui; Florero, Marilyn; Lin, Alyse; Moein, Anita; Wang, Rena; Bremer, Meire; Kokubu, Serika; Serone, Adrian P.; Hanze, Eva L.; Viberg, Anders; Morimoto, Alyssa M.; Winter, Helen R.; Katsumoto, Tamiko R.
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 103:Issue 6(2018)
Page Start:
1020
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗